Stereochemistry | ACHIRAL |
Molecular Formula | 2Cr.3O4S |
Molecular Weight | 392.18 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=GRWVQDDAKZFPFI-UHFFFAOYSA-H
InChI=1S/2Cr.3H2O4S/c;;3*1-5(2,3)4/h;;3*(H2,1,2,3,4)/q2*+3;;;/p-6
Molecular Formula | Cr |
Molecular Weight | 51.9961 |
Charge | 3 |
Count |
MOL RATIO
2 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | O4S |
Molecular Weight | 96.063 |
Charge | -2 |
Count |
MOL RATIO
3 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. | 1994 Jun |
|
Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate. | 1999 Dec |
|
Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats. | 2007 Oct |
|
The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment. | 2017 Sep 21 |
Patents
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10101-53-8 | PRIMARY | |||
|
90402 | PRIMARY | RxNorm | ||
|
53471 | PRIMARY | |||
|
233-253-2 | PRIMARY | |||
|
300000044724 | PRIMARY | |||
|
Y0C99N5TMZ | PRIMARY | |||
|
DTXSID20890642 | PRIMARY | |||
|
24930 | PRIMARY | |||
|
m3504 | PRIMARY | Merck Index | ||
|
Y0C99N5TMZ | PRIMARY | |||
|
CHROMIUM(III) SULFATE | PRIMARY | |||
|
2543 | PRIMARY | |||
|
51151 | PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |